Biolase Technology!!! - 500 Beiträge pro Seite
eröffnet am 07.06.01 12:46:10 von
neuester Beitrag 02.07.01 22:42:22 von
neuester Beitrag 02.07.01 22:42:22 von
Beiträge: 5
ID: 416.928
ID: 416.928
Aufrufe heute: 0
Gesamt: 610
Gesamt: 610
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 28 Minuten | 10344 | |
vor 45 Minuten | 6021 | |
vor 14 Minuten | 5544 | |
vor 25 Minuten | 3342 | |
heute 17:14 | 3141 | |
vor 41 Minuten | 2932 | |
vor 10 Minuten | 2349 | |
vor 11 Minuten | 2332 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 2. | 18.720,47 | -0,29 | 151 | |||
2. | 8. | 10,000 | -3,29 | 90 | |||
3. | 3. | 159,18 | +1,74 | 74 | |||
4. | 1. | 0,1960 | -9,68 | 68 | |||
5. | 26. | 4,8960 | +80,93 | 52 | |||
6. | 18. | 12,332 | +49,35 | 45 | |||
7. | 9. | 28,56 | +76,21 | 39 | |||
8. | 11. | 6,9780 | +2,62 | 38 |
Patenterweiterung und Q2 nahe dem break even!!!!!
news
SAN CLEMENTE, Calif., May 31 /PRNewswire/ -- BIOLASE Technology, Inc. (Nasdaq: BLTI - news) was granted an additional new patent by the United States Patent and Trademark Office in May 2001, strengthening their patent portfolio for the Waterlase(TM) technology. The patent, U.S. patent 6,231,567 B1, is a continuation in part of patents 5,741,247 and 5,968,037, which relate to technology using lasers with atomized fluid particles, such as water, to cut tissues and industrial materials. The new patent covers a vast field of applications in medical and non-medical industries.
This new patent is very significant to BIOLASE because it provides broader, more expanded coverage of the technology. This increases the barriers which others would have to overcome to avoid infringement.
The patent has 68 claims, 7 of which are independent. The claims are broad and cover the numerous embodiments of the invention. The apparatus described in the claims is an electromagnetic (EM) energy source, which could be a laser or any other EM energy source with a wavelength that is highly absorbed by liquid particles, which therefore produces forces capable of cutting any target surface such as living tissue, tooth, glass, crystalline material or a semiconductor chip surface.
Jeffrey W. Jones, BIOLASE CEO and president, noted, ``This new patent clarifies and broadens the scope of the company`s proprietary foundation in the use of lasers with water both in dentistry and other areas. It is the latest in a family of related BIOLASE patents, and it brings together and strengthens various previous claims under one umbrella. This patent is a cornerstone of our technology with claims that are supported by the disclosure of the original HydroKinetic® patent.
``Although we have obtained broad coverage in the past, we continue to work with the USPTO to obtain broader and stronger patents. The claims of this patent provide great protection for some particular aspects of the HydroKinetic cutting process. In this patent, the invention is directed to a new area of technology wherein energy is focused above the target surface. With this technology, the peak energy from the EM energy source (laser source) is directed in a highly engineered distribution of fluid particles. The layer of fluid particles generated by the atomizer can also be controlled to produce different distributions of fluid particles that allow for variability in the cutting resolution and depth.``
Jones continued, ``The technology covered in this patent is fully integrated in our Waterlase hard and soft tissue dental laser, which is sold worldwide. This patent increases the already-strong protection for our platform technology, which is critical for the short and long-term advancement of the company.``
news
SAN CLEMENTE, Calif., May 31 /PRNewswire/ -- BIOLASE Technology, Inc. (Nasdaq: BLTI - news) was granted an additional new patent by the United States Patent and Trademark Office in May 2001, strengthening their patent portfolio for the Waterlase(TM) technology. The patent, U.S. patent 6,231,567 B1, is a continuation in part of patents 5,741,247 and 5,968,037, which relate to technology using lasers with atomized fluid particles, such as water, to cut tissues and industrial materials. The new patent covers a vast field of applications in medical and non-medical industries.
This new patent is very significant to BIOLASE because it provides broader, more expanded coverage of the technology. This increases the barriers which others would have to overcome to avoid infringement.
The patent has 68 claims, 7 of which are independent. The claims are broad and cover the numerous embodiments of the invention. The apparatus described in the claims is an electromagnetic (EM) energy source, which could be a laser or any other EM energy source with a wavelength that is highly absorbed by liquid particles, which therefore produces forces capable of cutting any target surface such as living tissue, tooth, glass, crystalline material or a semiconductor chip surface.
Jeffrey W. Jones, BIOLASE CEO and president, noted, ``This new patent clarifies and broadens the scope of the company`s proprietary foundation in the use of lasers with water both in dentistry and other areas. It is the latest in a family of related BIOLASE patents, and it brings together and strengthens various previous claims under one umbrella. This patent is a cornerstone of our technology with claims that are supported by the disclosure of the original HydroKinetic® patent.
``Although we have obtained broad coverage in the past, we continue to work with the USPTO to obtain broader and stronger patents. The claims of this patent provide great protection for some particular aspects of the HydroKinetic cutting process. In this patent, the invention is directed to a new area of technology wherein energy is focused above the target surface. With this technology, the peak energy from the EM energy source (laser source) is directed in a highly engineered distribution of fluid particles. The layer of fluid particles generated by the atomizer can also be controlled to produce different distributions of fluid particles that allow for variability in the cutting resolution and depth.``
Jones continued, ``The technology covered in this patent is fully integrated in our Waterlase hard and soft tissue dental laser, which is sold worldwide. This patent increases the already-strong protection for our platform technology, which is critical for the short and long-term advancement of the company.``
Hi
Biolaser läuft übrigens nicht schlecht seit dieser Meldung.
Waren schnelle 72%. Hat sogar Nanophase überholt wo ich im
schnitt mit 7,80€ eingestiegen bin !!!
Loudeye holt auch mit riesen Schritten auf. Mal sehen wer nächste
Woche die Nase forne hat ? War übrigens eine gute Woche trotz
schlechter Marktlage.
Gruß
SG
Biolaser läuft übrigens nicht schlecht seit dieser Meldung.
Waren schnelle 72%. Hat sogar Nanophase überholt wo ich im
schnitt mit 7,80€ eingestiegen bin !!!
Loudeye holt auch mit riesen Schritten auf. Mal sehen wer nächste
Woche die Nase forne hat ? War übrigens eine gute Woche trotz
schlechter Marktlage.
Gruß
SG
Ich denke die Aktie ist ein Investment wert, bin heute morgen rein, und heute abend schiesst das Ding in Amerika 8 Prozent in die Höhe. Dazu die 11 Prozent in Deutschland, damit (davon) könnt ich leben....
Cowboy
Cowboy
Biolase knüpft an die Erfolgsstory der letzten Wochen an, und legt weiter zu. Doch ist die Ralley jetzt bestimmt noch nicht zu Ende, die Aktie birgt noch Reserven....
Cowboy
Cowboy
Hi
Biolase ist recht gut gelaufen und hat bestimmt bis 15€ Potential
auf zwei Jahre. Bin schon ende Februar rein (bei 2,65€)
Es hat sich gelohnt einen Tiefpunkt zu nutzen.
Weitere Einstiegskandidaten bilden sich momentan in meiner Watchliste
Werde diesen Wert aber noch einbischen halten , der läuft bestimmt noch.
Gruß
SG
Biolase ist recht gut gelaufen und hat bestimmt bis 15€ Potential
auf zwei Jahre. Bin schon ende Februar rein (bei 2,65€)
Es hat sich gelohnt einen Tiefpunkt zu nutzen.
Weitere Einstiegskandidaten bilden sich momentan in meiner Watchliste
Werde diesen Wert aber noch einbischen halten , der läuft bestimmt noch.
Gruß
SG
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
151 | ||
90 | ||
74 | ||
68 | ||
52 | ||
45 | ||
39 | ||
38 | ||
38 | ||
31 |
Wertpapier | Beiträge | |
---|---|---|
24 | ||
24 | ||
22 | ||
19 | ||
18 | ||
18 | ||
18 | ||
17 | ||
17 | ||
17 |